Capsid & Tail
Loading issues…
- International Conference on Bacteriophage Research and Antimicrobial Resistance: Meeting RecapThis week, Dr. Ramesh Nachimuthu reflects on the ICBRAMR conference, which took place in Vellore, India in December 2019 and focused on the promise of phages in the fight against antimicrobial resistance.
- Patient perspective: My life since learning of phage therapy one year agoThis week, Ella Balasa, a cystic fibrosis patient who received phage therapy from Yale researchers in 2019, tells her story.
- Phage manufacturing challenges and how academic-commercial collaboration can helpThis week, we bring you an interview with Danish Malik, Senior Lecturer at Loughborough University. He tells us about current challenges with phage manufacturing, including what phage companies need to think about, and how…
- How can phage companies protect their intellectual property?This week, we bring you an interview with Michele Wales, founder of the legal firm InHouse Patent Counsel. She tells us about the unique challenges phage companies face in protecting their IP, and why she's optimistic about what's to come.
- Phage Futures Europe 2019: Meeting RecapLast Fall, we attended the Phage Futures Europe conference, which covered phage commercialization with a focus on how European regulators are thinking about phage therapy.
This week, we present our full recap of that event, just in time to…
- Bringing software to the phage fieldHappy New Year, phage enthusiasts! This week, we share how we plan to help the phage research community systematize and standardize phage data collection in 2020.
- Phages against porcine enterotoxigenic E. coli: a Christmas taleThis week, Dr. Michela Gambino, a postdoc in the PHAGEBio group at the University of Copenhagen, tells us about the importance of pork in Denmark, and about their group's search for phages against E. coli in pigs.
- Raising awareness of phage therapy among physiciansThis week, Aël Hardy, an MD-PhD student at Forschungszentrum Jülich in Germany, explores physicians’ awareness about phages and how it could be improved. He interviewed two French physicians who recently used phages to treat some of their…
- A new phage consortium hosts its first public lectureThis week, Dr. Urmi Bajpai, a phage researcher in New Delhi, India and co-creator of the International Bacteriophage Research Consortium, tells us about a public phage therapy lecture her Consortium held last month to raise awareness of…
- Phage training reaches East AfricaThis week, Dr. Atunga Nyachieo and Ivy Mutai of the Institute of Primate Research in Nairobi, Kenya tell us about how phage research training began at their institute in 2017, how it continues to grow, and the impact it's had so far.
- Constructing phage libraries for therapyThis week, we're highlighting a paper published by Shelley Gibson and colleagues at Baylor College of Medicine and the VA Medical Center in Houston, Texas. They've constructed and characterized phage libraries against three pathogens, and…
- The state of antibiotic resistance in the US and CanadaThis week, we provide an overview of two major new antibiotic resistance reports: one from the US (CDC) and one from Canada. We provide a few takeaways, briefly compare the reports, and hope to inspire you to dive in to learn more about the…
- The struggles, the pain, and the prospects: Doing phage work in a resource-limited settingThis week, Nnaemeka Emmanuel Nnadi, a Lecturer at Plateau State University in Bokkos, Nigeria, shares some of the challenges his phage research lab faces due to their resource-limited setting.
- MB Pharma: Building on phage therapy traditions in the Czech RepublicThis week, Milan Buňata of MB Pharma, a Czech company that's recently gotten into phage, tells us about phage therapy traditions in the Czech Republic, what their company is working toward, and their interest in collaborating with the phage…
- Year One of Capsid & TailWe’ve been publishing Capsid & Tail for a year now, and while some of you have been here since the early days, we know many of you have found us relatively recently. So this week, we’ve gone through our archive to dig up some of our…
- Phages for musculoskeletal infectionsThis week we highlight a recent paper on using phage therapy to treat severe musculoskeletal infections (osteomyelitis). A multidisciplinary group in Belgium made up of surgeons, infectious disease physicians, pharmacists, microbiologists…
- The Nagoya Protocol and phages: an introductionYou may have heard of the Nagoya Protocol in the context of isolating or sharing phages or bacteria. But what is the Nagoya Protocol, and how does it apply to phage research and development? This week, we've put together a primer to help…
- Using Galaxy for phage genome annotationThis week, we're covering an introductory phage genome annotation workshop that was taught at the 2019 Evergreen Phage Conference. The workshop, Phage Genomics with Galaxy and Apollo, was taught by Jason Gill, a professor at the Center for…
- Optimizing phage amplificationAre you a company or lab that needs to produce phages in high quantities? This week, Craig Loftus of Cellexus tells us about how their CellMaker system can help you get higher phage titres in less time and with less cleaning.
- Evergreen Phage 2019: Meeting RecapHello phage people! It’s been about a month since Evergreen, and we’re ready with our wrap-up post. We’ve covered highlights, themes, and what really excited us about the conference!
